SALT LAKE CITY--(BUSINESS WIRE)--Maximizing production capacity, completing placement of systems in multiple hospitals, and witnessing early clinical successes with the MicroThermX Microwave Ablation (MicroThermX) line of products have paved the way for BSD Medical Corporation (Nasdaq: BSDM) to take its sales and distribution strategy to the next level. BSD is in the final process of establishing both domestic and international distribution networks dedicated to selling its exciting new microwave ablation product line. BSD has elected to pursue the strategy of utilizing a network of specialty distribution firms focused on selling products in the field of interventional radiology, the target market for the Company’s ablation product line. The Company has identified seven regionally specific US firms that will provide as many as 60 sales representatives to promote, sell and service the MicroThermX product line throughout the United States. Early training of some of these specialty distributors is currently under way. BSD anticipates finalizing geographically exclusive distribution agreements with all of the identified firms in the coming weeks. Full sales coverage of the United States should be in place within the first quarter of calendar year 2011.
